News
8h
Zacks Investment Research on MSNPfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?
Wall Street expects a year-over-year decline in earnings on higher revenues when Pfizer (PFE) reports results for the quarter ...
6h
Barchart on MSNPfizer Stock Is a Value Play Ahead of Earnings - Investors Can Short PFE Puts for Income
Pfizer, Inc. (PFE) stock still looks cheap ahead of its upcoming Aug. 5 Q2 earnings release. Moreover, investors can make extra income by selling out-of-the-money (OTM) put options. This article ...
Pfizer Inc (NYSE:PFE) is one of the Top 10 Stocks Wall Street is Buzzing About These Days. Josh Brown, CEO of Ritholtz Wealth ...
Pfizer Inc. (NYSE:PFE) is among the 12 Best Ethical Companies to Invest in 2025. On July 24, 2025, Pfizer Inc. (NYSE:PFE) ...
I can’t ask you to do that because we are still on the verge of finding out what the Seagen acquisition does. Let’s give Dr.
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...
Turkish scientists say that Pfizer's COVID-19 vaccine can increase the risk of eye damage, causing vision loss. A new study ...
Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...
While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...
Pfizer agreed to an upfront payment of US$1.25 billion, US$150 million for mainland rights and a US$100 million equity ...
Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...
New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results